ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links1 made here, not in the record6 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07601737Nimotuzumab Combined WithImmunotherapy andChemotherapy in theTreatment of LocallyAdvanced Head and NeckSquamous Cell CarcinomaShanghai General Hospital, ShaPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSSquamous Cell Carcinoma of …The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionHead and Neck NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSNimotuzumabEntry “Nimotuzumab Injection”, read b…›Nov 18 · Rule based · TestedTestedTislelizumabIntervention entry›Nov 18 · Rule based · BackgroundBackgroundAlbumin-Bound PaclitaxelEntry “Albumin-Bound Paclitaxel /nab-…›Nov 18 · Rule based · BackgroundBackgroundCisplatinEntry “Cisplatin (Or Carboplatin)”, r…›Nov 18 · Rule based · BackgroundBackgroundPembrolizumabMade here · Found by reading; no entr…›Nov 1 · Claude Opus 5.5 · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pembrolizumab

Made here1 judgment on this link
NCT07601737gives it, found by reading the recordPembrolizumabDefined by Claude Opus 5.5Nov 1, 2026, 9:53 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1Pembrolizumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 18NimotuzumabRule based · role ruleTestedCurrent
Nov 18TislelizumabRule based · role ruleBackgroundCurrent
Nov 18Albumin-Bound PaclitaxelRule based · role ruleBackgroundCurrent
Nov 18CisplatinRule based · role ruleBackgroundCurrent
As of nowSquamous Cell Carcinoma of Head and NeckRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.